My Medical Gateway News

Once patients choose their preferred hospital and treatment package through MMG, the hospital advises exactly which diagnostic tests are required before treatment can proceed. Because private hospitals usually require recent test results less than 30 days old, patients should not rely on NHS pathways to obtain them quickly. MMG helps simplify the process by providing guidance, UK diagnostic partners and AI-generated estimates for travel, accommodation and testing costs, helping patients understand the true overall cost of treatment abroad from the outset.

One of the most important stages in arranging private treatment abroad is securing the diagnostic tests required by your chosen hospital before surgery or specialist treatment can be confirmed.

At MMG, we understand that this part of the process can initially feel unfamiliar for many UK patients, particularly those who have already spent months or even years within NHS pathways. Many patients assume that because they have already undergone scans, consultations or diagnostic investigations through the NHS, those same results can simply be reused indefinitely for private treatment abroad.

In reality, private hospitals across Europe almost always require recent diagnostic data before they can medically clear a patient for surgery or specialist procedures. In most cases, hospitals require tests, scans and blood work that are no more than 30 days old at the point of treatment confirmation.

This is not unique to treatment abroad. It is standard clinical practice in modern private healthcare and reflects the need for consultants and anaesthetists to make decisions based on current medical information rather than older investigations which may no longer accurately reflect the patient’s condition.

The good news is that MMG’s platform has been specifically designed to guide patients through this process as simply and transparently as possible.

Once you have chosen your preferred treatment package and selected your hospital on the MMG platform, you will be informed during the booking process exactly which diagnostic tests are required for your specific treatment before you can be formally cleared for surgery. Depending on the procedure, this may include MRI scans, CT scans, X-rays, ECGs, blood tests or specialist investigations.

For patients seeking orthopaedic surgery abroad, spinal surgery, cardiology procedures or other specialist treatment, this stage is critical because it allows the consultant-led medical team to confirm both suitability and safety before surgery proceeds.

Importantly, responsibility for securing these diagnostic tests rests with you, the patient. While some patients may attempt to obtain updated tests through their NHS GP or local NHS services, MMG strongly advises patients not to rely on NHS pathways if they are seeking rapid treatment abroad.

The reality is that NHS diagnostic systems are often extremely slow, particularly for non-urgent repeat imaging or updated pre-operative investigations. Even patients who have already been diagnosed by the NHS frequently discover that obtaining refreshed scans or blood tests through NHS routes can take weeks or months. In many cases, this delay becomes the single biggest obstacle preventing faster treatment.

For patients actively looking to avoid NHS waiting lists and secure consultant-led surgery abroad within weeks, private diagnostics are usually the fastest and most reliable solution.

This is why MMG works to simplify the process by helping patients identify appropriate UK diagnostic providers and by supporting them throughout the onboarding journey, including a 10% discount through Scan.com for all imaging diagnostic tests. Patients can arrange tests privately in the UK, forward the results to their chosen European hospital (while keeping MMG informed so we can monitor and follow-up with your hospital) and receive rapid consultant review from their chosen European hospital before travelling.

In many cases, once diagnostic results have been uploaded and reviewed, surgery can be scheduled within approximately six weeks of diagnostic clearance.

Transparency around costs is another major part of the MMG model.

One concern many UK patients have when considering treatment abroad is uncertainty about the “hidden costs” beyond the hospital package itself. MMG addresses this directly through AI-generated cost estimates designed to help patients understand the likely overall cost of treatment from the outset.

When patients review treatment packages on the MMG platform, the system provides estimated additional costs that are not included within the hospital’s all-inclusive treatment package. These estimates include three items: travel to and from the country of treatment, accommodation and sustenance outside the hospital stay, pre- and post-treatment diagnostic tests carried out in the UK.

This allows patients to build a much clearer picture of their likely total expenditure before proceeding with the booking process.

Importantly, these estimates are generated before the patient pays the initial 10 per cent deposit, helping avoid uncertainty and giving patients greater confidence and financial transparency when comparing treatment options abroad.

For many UK patients, this level of clarity is one of the major advantages of arranging treatment through MMG rather than attempting to organise medical travel independently. The platform combines accredited European hospitals, consultant-led treatment pathways, transparent fixed-price surgery packages and structured patient support designed specifically for people seeking faster and more affordable alternatives to NHS waiting lists and expensive UK private healthcare.

Ultimately, diagnostics are not simply an administrative step. They are the gateway that allows hospitals to safely and rapidly move patients towards treatment. By ensuring patients understand exactly what is required, how quickly tests should be arranged and what costs are likely to be involved, MMG helps turn what can initially feel like a confusing process into a clear and manageable pathway towards faster specialist treatment abroad.